Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1987 Jun;62(6):573–575. doi: 10.1136/adc.62.6.573

Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.

H P McDowell, P Shears, C A Hart, J Martin
PMCID: PMC1778445  PMID: 3476023

Abstract

A cross sectional study was carried out in children receiving treatment for acute lymphoblastic leukaemia to determine the prevalence of trimethoprim resistant organisms in their gut flora and to compare this with a control population. There was a significantly higher prevalence of trimethoprim resistant bacteria in the study group (61%) compared with controls (14%). A longitudinal study showed that emergence of these organisms was intermittent during treatment.

Full text

PDF
573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barth P. T., Datta N., Hedges R. W., Grinter N. J. Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons. J Bacteriol. 1976 Mar;125(3):800–810. doi: 10.1128/jb.125.3.800-810.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dekker A. W., Rozenberg-Arska M., Sixma J. J., Verhoef J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med. 1981 Nov;95(5):555–559. doi: 10.7326/0003-4819-95-5-555. [DOI] [PubMed] [Google Scholar]
  3. Enno A., Catovsky D., Darrell J., Goldman J. M., Hows J., Galton D. A. Co-trimoxazole for prevention of infection in acute leukaemia. Lancet. 1978 Aug 19;2(8086):395–397. doi: 10.1016/s0140-6736(78)91865-2. [DOI] [PubMed] [Google Scholar]
  4. Goorin A. M., Hershey B. J., Levin M. J., Siber G. R., Gelber R. D., Flynn K., Lew M., Beckett K., Blanding P., Sallan S. E. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia. Pediatr Infect Dis. 1985 May-Jun;4(3):265–269. doi: 10.1097/00006454-198505000-00012. [DOI] [PubMed] [Google Scholar]
  5. Guerrant R. L., Wood S. J., Krongaard L., Reid R. A., Hodge R. H. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone. Antimicrob Agents Chemother. 1981 Jan;19(1):33–38. doi: 10.1128/aac.19.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hart C. A. Nosocomial gentamicin- and multiply-resistant enterobacteria at one hospital. Factors associated with carriage. J Hosp Infect. 1982 Jun;3(2):165–172. doi: 10.1016/0195-6701(82)90009-3. [DOI] [PubMed] [Google Scholar]
  7. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  8. Kauffman C. A., Liepman M. K., Bergman A. G., Mioduszewski J. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora. Am J Med. 1983 Apr;74(4):599–607. doi: 10.1016/0002-9343(83)91017-3. [DOI] [PubMed] [Google Scholar]
  9. Lewis I. J., Mainwaring D., Martin J. Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia. Arch Dis Child. 1982 Sep;57(9):663–667. doi: 10.1136/adc.57.9.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. doi: 10.1056/NEJM198201213060302. [DOI] [PubMed] [Google Scholar]
  11. Pearson N. J., Towner K. J., McSherry A. M., Cattell W. R., O'Grady F. Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection. Lancet. 1979 Dec 8;2(8154):1205–1208. doi: 10.1016/s0140-6736(79)92331-6. [DOI] [PubMed] [Google Scholar]
  12. Starke I. D., Donnelly P., Catovsky D., Darrell J., Johnson S. A., Goldman J. M., Galton D. A. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. Lancet. 1982 Jan 2;1(8262):5–6. doi: 10.1016/s0140-6736(82)92553-3. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES